Literature DB >> 31866361

Inhaled nitric oxide use in neonates: Balancing what is evidence-based and what is physiologically sound.

Laurie G Sherlock1, Clyde J Wright1, John P Kinsella1, Cassidy Delaney2.   

Abstract

Inhaled nitric oxide is a powerful therapeutic used in neonatology. Its use is evidenced-based for term and near-term infants with persistent pulmonary hypertension; however, it is frequently used off-label both in term and preterm babies. This article reviews the off-label uses of iNO in infants. Rationale is discussed for a selective application of iNO based on physiologically guided principles, and new research avenues are considered.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Bronchopulmonary dysplasia; Neonate; Nitric oxide; Persistent pulmonary hypertension of the newborn; Pulmonary arterial hypertension; Respiratory failure

Year:  2019        PMID： 31866361      PMCID： PMC7594166          DOI： 10.1016/j.niox.2019.12.001

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN： 1089-8603            Impact factor:   4.427


  79 in total

1.  Inhaled nitric oxide effects on lung structure and function in chronically ventilated preterm lambs.

Authors:  Richard D Bland; Kurt H Albertine; David P Carlton; Amy J MacRitchie
Journal:  Am J Respir Crit Care Med       Date:  2005-06-23       Impact factor: 21.405

2.  Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. The Neonatal Inhaled Nitric Oxide Study Group (NINOS).

Authors: 
Journal:  Pediatrics       Date:  1997-06       Impact factor: 7.124

3.  Congenital diaphragmatic hernia.

Authors:  S Kotecha; A Barbato; A Bush; F Claus; M Davenport; C Delacourt; J Deprest; E Eber; B Frenckner; A Greenough; A G Nicholson; J L Antón-Pacheco; F Midulla
Journal:  Eur Respir J       Date:  2011-10-27       Impact factor: 16.671

4.  Bleeding time prolongation and NO inhalation.

Authors:  M Högman; C Frostell; H Arnberg; G Hedenstierna
Journal:  Lancet       Date:  1993-06-26       Impact factor: 79.321

5.  Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.

Authors:  Peter M Mourani; Marci K Sontag; Adel Younoszai; Joshua I Miller; John P Kinsella; Christopher D Baker; Brenda B Poindexter; David A Ingram; Steven H Abman
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

6.  Evaluation of Variability in Inhaled Nitric Oxide Use and Pulmonary Hypertension in Patients With Congenital Diaphragmatic Hernia.

Authors:  Luke R Putnam; Kuojen Tsao; Francesco Morini; Pamela A Lally; Charles C Miller; Kevin P Lally; Matthew T Harting
Journal:  JAMA Pediatr       Date:  2016-12-01       Impact factor: 16.193

7.  Pulmonary vein stenosis: prematurity and associated conditions.

Authors:  David M Drossner; Dennis W Kim; Kevin O Maher; William T Mahle
Journal:  Pediatrics       Date:  2008-09       Impact factor: 7.124

8.  Race Effects of Inhaled Nitric Oxide in Preterm Infants: An Individual Participant Data Meta-Analysis.

Authors:  Lisa M Askie; Lucy C Davies; Michael D Schreiber; Anna Maria Hibbs; Philip L Ballard; Roberta A Ballard
Journal:  J Pediatr       Date:  2017-12-11       Impact factor: 4.406

9.  Inhaled nitric oxide in premature infants with the respiratory distress syndrome.

Authors:  Michael D Schreiber; Karen Gin-Mestan; Jeremy D Marks; Dezheng Huo; Grace Lee; Pimol Srisuparp
Journal:  N Engl J Med       Date:  2003-11-27       Impact factor: 91.245

10.  Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management.

Authors:  Erika B Rosenzweig; Steven H Abman; Ian Adatia; Maurice Beghetti; Damien Bonnet; Sheila Haworth; D Dunbar Ivy; Rolf M F Berger
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671
View more
  7 in total

Review 1.  "CO in a pill": Towards oral delivery of carbon monoxide for therapeutic applications.

Authors:  Xiaoxiao Yang; Wen Lu; Minjia Wang; Chalet Tan; Binghe Wang
Journal:  J Control Release       Date:  2021-09-02       Impact factor: 11.467

2.  Correlation of NO and ET-1 Levels with Blood Pressure Changes in Hemodialysis Patients after Arteriovenous Fistula Surgery.

Authors:  Yanli Li; Hanxiao Lu; Yu Sun
Journal:  Front Surg       Date:  2022-05-16

Review 3.  Advances in the Study of Inhaled Formulations for the Treatment of Pulmonary Arterial Hypertension.

Authors:  Fei Han; Yongqi Chen; Shijie Li; Yankun Yang; Zhonghu Bai
Journal:  Appl Bionics Biomech       Date:  2022-06-02       Impact factor: 1.664

Review 4.  Therapeutic Effects of Inhaled Nitric Oxide Therapy in COVID-19 Patients.

Authors:  Nikolay O Kamenshchikov; Lorenzo Berra; Ryan W Carroll
Journal:  Biomedicines       Date:  2022-02-03

Review 5.  Roles of Nitric Oxide in Brain Ischemia and Reperfusion.

Authors:  Yijie Wang; Fenfang Hong; Shulong Yang
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

Review 6.  Pulmonary hypertension in the child with bronchopulmonary dysplasia.

Authors:  Kelsey W Malloy; Eric D Austin
Journal:  Pediatr Pulmonol       Date:  2021-08-05

7.  Inhaled Pharmacotherapy for Neonates: A Narrative Review.

Authors:  Gustavo Rocha
Journal:  Turk Arch Pediatr       Date:  2022-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.